Abstract
A therapeutical trial was conducted with pentosanpolysulphate (Elmiron®) in 24 patients with chronic non-bacterial prostatitis. The study was double-blind and 10 patients received Elmiron® 200 mg × 2 daily while 14 received a placebo. A beneficial effect (p<0.01) was registered on symptoms from muscles and joints. A side-effect observed was a tendency to develop diarrhoea in a few patients prone to gastrointestinal disturbances previously.